| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V69510 | Chimaphilin | 482-70-2 | Chimaphilin is an IGF-1R inhibitor (IC50= 0.086 μM). |
|
V69502 | Dusigitumab (MEDI 573) | 1204390-13-5 | Dusigitumab (MEDI 573) is a human IgG2λ monoclonal antibody (mAb) that specifically targets IGF2 and IGF1. |
|
V69507 | Figitumumab (CP-751871) | 943453-46-1 | Figitumumab (CP-751871) is a potent, fully human anti-insulin-like growth factor 1 receptor (IGF1R) monoclonal antibody (mAb). |
|
V69505 | Ganitumab (AMG 479; Human Anti-IGF1R Recombinant Antibody) | 905703-97-1 | Ganitumab (AMG 479) is a recombinant human type 1 insulin-like growth factor receptor (IGF1R) monoclonal antibody (mAb). |
|
V69509 | IGF-1R inhibitor-2 | 1116236-15-7 | IGF-1R inhibitor-2 (example 121) is an inhibitor (blocker/antagonist) of the insulin-like growth factor-1 receptor (IGF-1R). |
|
V80351 | IGF-I (24-41) (TFA) (Insulin-like Growth Factor I (24-41) (TFA)) | IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) TFA is the amino acid (AA) fragment 24 to 41 of insulin-like growth factor I. | |
|
V80352 | IGF-I (30-41) (TFA) (Insulin-like Growth Factor I (30-41) (TFA)) | IGF-I (30-41) (TFA) is the 30 to 41 amino acid (AA) fragment of insulin-like growth factor I. | |
|
V69508 | Mecasermin (Human IGF-I; FK 780) | 68562-41-4 | Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). |
|
V76719 | NBI-31772 hydrate | NBI-31772 hydrate is a potent inhibitor of the interaction between insulin-like growth factor IGF and IGFBP. | |
|
V69506 | Robatumumab (Sch 717454; 19D12) | 934235-44-6 | Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor 1 receptor) antibody. |
|
V69503 | Teprotumumab | 1036734-93-6 | Teprotumumab is a human monoclonal antibody (mAb) that blocks the IGF-1 receptor (IGF-1R). |
|
V69501 | Veligrotug (Veligrotug) | 2728655-31-8 | Veligrotug is an IgG1-kappa, anti-IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody (mAb). |
|
V69504 | Xentuzumab (BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody) | 1417158-65-6 | Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant humanized monoclonal antibody (mAb) targeting the IGF ligands IGF1 and IGF2. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
